Endometriosis
Conditions
Brief summary
This study will investigate the clinical performance and diagnostic accuracy of the Mitomic® Endometriosis Test (MET) compared to laparoscopic diagnosis in a prospective clinical study in females presenting with symptoms suggestive of endometriosis. This study will recruit patients with suspected endometriosis who have been referred for a diagnostic laparoscopy. Patients will complete a questionnaire about their endometriosis symptoms and a sample of blood will be taken prior to their laparoscopy and sent to the laboratory for the MET to be run. This study aims to first enroll 104 subjects to support the clinical validation necessary for launch of the test as an LDT. Following this, we plan a study extension with an aim to enroll up to 900 more (for a total of 1000) subjects to enable more precise estimation of performance characteristics, characterization of test performance in subtypes of endometriosis, to better understand the relationship between test results and secondary endpoints such as symptoms and demographic variables, and to establish a bank of samples to support future test development.
Interventions
DIAGNOSTIC_TESTThe Mitomic Endometriosis Test (MET) blood test for early detection of endometriosis
Patients will complete a questionnaire about their endometriosis symptoms and a sample of blood will be taken prior to their laparoscopy and sent to the laboratory for testing.
Sponsors
Pearsanta, Inc
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Healthy volunteers
Yes
Inclusion criteria
1. Be female, between menarche and menopause who present with symptoms of endometriosis at time of blood collection and are scheduled to undergo their first laparoscopic procedure for the diagnosis of endometriosis 2. Provide a blood sample prior to surgical procedure or administration of drugs related to the surgical procedure (i.e. anaesthetics, antibiotics) 3. Be fit to undergo all procedures listed in protocol 4. Be able to provide written informed consent
Exclusion criteria
1. Has had a prior surgical diagnosis of endometriosis at time of blood collection 2. Is unable to communicate in written and spoken English 3. Has any other condition, which in the opinion of the investigator, would make the subject not a suitable candidate for the study. This reason must be recorded on the CRF
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Presence or absence of endometriosis | up to 5 years | Presence or absence of endometriosis as determined by standard-of-care diagnostic laparoscopy |
Countries
United States
Contacts
Primary ContactStephen A Varvel, Ph.D.
Outcome results
None listed